These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10089028)

  • 1. Hodgkin's and Castleman's disease in a patient with systemic mastocytosis.
    Saletti P; Ghielmini M; Scali G; Pedrinis E; Guéneau M; Cavalli F
    Ann Hematol; 1999 Feb; 78(2):97-100. PubMed ID: 10089028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiofollicular lymph node transformation in Hodgkin's lymphoma.
    Drut R; Larregina A
    Pediatr Pathol; 1991; 11(6):903-8. PubMed ID: 1775404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastocytosis and co-existent non-Hodgkin's lymphoma and myeloproliferative disorders.
    Hutchinson RM
    Leuk Lymphoma; 1992 May; 7(1-2):29-36. PubMed ID: 1472931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.
    Momoi A; Kojima M; Sakai T; Ajiro J; Isahai N; Nagai K; Aoki S
    Int J Hematol; 2013 Feb; 97(2):275-9. PubMed ID: 23359301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cell variant of Castleman's disease occurring concurrently with Hodgkin's disease in the neck.
    Frank DK; Charney D; Kashani A
    Head Neck; 2001 Feb; 23(2):166-9. PubMed ID: 11303634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
    J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
    Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
    Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficulty in the staging of Hodgkin's disease due to the coexistence of reactive lymphadenopathy.
    Richards EM; Marcus RE
    Leuk Lymphoma; 1993 Mar; 9(4-5):413-8. PubMed ID: 7688629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of a case of localized Castleman's disease with progression to malignant lymphoma.
    Vasef M; Katzin WE; Mendelsohn G; Reydman M
    Am J Clin Pathol; 1992 Dec; 98(6):633-6. PubMed ID: 1462961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.
    Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V
    Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
    Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A
    Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and toxicity of vinblastine, bleomycin, and methotrexate with involved-field radiotherapy in clinical stage IA and IIA Hodgkin's disease: a British National Lymphoma Investigation pilot study.
    Bates NP; Williams MV; Bessell EM; Vaughan Hudson G; Vaughan Hudson B
    J Clin Oncol; 1994 Feb; 12(2):288-96. PubMed ID: 7509382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkitt cell leukemia following treatment of Hodgkin's disease: report of a case and review of the literature.
    Krikler SH; Bain GO; Gordon PA
    Am J Hematol; 1984 Aug; 17(2):203-8. PubMed ID: 6331765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the therapy of Hodgkin's disease in elderly patients. The Piemonte Hodgkin's Disease Register (PHDR).
    Levis A
    Hematol Oncol; 1993; 11 Suppl 1():78-84. PubMed ID: 7683625
    [No Abstract]   [Full Text] [Related]  

  • 15. Hodgkin's disease of middle ear and mastoid.
    Solanellas J; Esteban F; Soldado L; López-Lacomba D; Hierro C; Jimenez JM
    J Laryngol Otol; 1996 Sep; 110(9):869-71. PubMed ID: 8949300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Hodgkin's disease of the bone.
    Fried G; Ben Arieh Y; Haim N; Dale J; Stein M
    Med Pediatr Oncol; 1995 Mar; 24(3):204-7. PubMed ID: 7530802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive combination chemotherapy and X-irradiation in Hodgkin's disease.
    Moxley JH; De Vita VT; Brace K; Frei E
    Cancer Res; 1967 Jul; 27(7):1258-63. PubMed ID: 4952914
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support.
    Advani R; Warnke R; Rosenberg S
    Ann Oncol; 1999 Oct; 10(10):1207-9. PubMed ID: 10586338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloidosis in Hodgkin's and Castleman's diseases.
    Barişta I; Benekli M; Tekuzman G
    Ann Oncol; 1999 Aug; 10(8):998-9. PubMed ID: 10509168
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
    Lajoie G; Kumar S; Min KW; Silva FG
    Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.